Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
A phase 3 trial of Cadonilimab, CAPOX, Capecitabine in colorectal cancer, run by Akeso, now recruiting.
Overview
Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer is a phase 3 interventional study registered as NCT07412613 by Akeso, with 386 participants planned, started 2026-04-15 and due to reach its primary completion in 2030-06-15. Interventions recorded: Cadonilimab (AK104), Oxaliplatin, Capecitabine, 5- Fluorouracil, Calcium Folinate. Conditions listed: Resectable Colon Cancer, MSI-H/dMMR Colorectal Cancer. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Capecitabine, Colorectal cancer.
- TrialA Study of AK104 With Chemotherapy as First-line Treatment in Patients With Advanced Pancreatic Cancer
Shares Leucovorin (folinic acid), Cadonilimab, Akeso.
- TrialBOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialA Phase Ib/II Clinical Study on AK112 Combined or Not Combined With AK119 in pMMR/MSS Colorectal Cancer
Shares Leucovorin (folinic acid), CAPOX (capecitabine, oxaliplatin), Akeso, Colorectal cancer.
- TrialA Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection
Shares Cadonilimab, Akeso.
- TrialA Phase III Clinical Study of Cadonilimab Plus SOX as Perioperative Treatment for Patients With Resectable G/GEJ Adenocarcinoma
Shares Cadonilimab, Akeso.
- TrialA Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
Shares CAPOX (capecitabine, oxaliplatin), Akeso, Capecitabine, Colorectal cancer.
- TrialA Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer
Shares Cadonilimab, Akeso.